Dermatology Maui Derm Hawaii 2023 January 23-27, 2023 — Maui, Hawaii New Oral Drug Class Highly Specific for Moderate-to-Severe Plaque Psoriasis Download 5 PowerPoint slides
Cardiology LDL-C: Expert Discussion Dr. Arsenault & Dr. McPherson — Length: 08:06 A Novel Approach for Sustained Tight Control of LDL-C Watch Presentation
Infectious Disease HIV: Expert Discussion Dr. Hedgcock & Dr. Arbess — Length: 08:12 A Pragmatic Framework for ART Regimens in Clinical Practice Watch Presentation
ophthalmology Retinal Conditions: Expert Interview Dr. Cynthia Qian — Length: 05:23 Clinical Relevance of Anti-VEGF Treatment Properties Watch Presentation
Hematology Waldenström Macroglobulinemia: Expert Interview Dr. Laurie H Sehn — Length: 06:19 A Canadian Perspective on the Role of BTK Inhibitors in the Treatment of WM Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Carolyn Owen — Length: 05:00 ALPINE Trial Demonstrates Superior Response of Second-Generation BTK Inhibitor in CLL/SLL Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana ALPINE Head-to-head Trial, Second-generation BTK Inhibitor Shown to be More Effective and Safer in CLL Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Dennis Kim — Length: 05:18 STAMP Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana Novel Small Molecule Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Laurie H. Sehn — Length: 05:00 New Data Shifts Risk-benefit of BTK Inhibitors in CLL/SLL Watch Presentation
rheumatology American College of Rheumatology (ACR) Convergence 2022: Expert Interview Dr. Tom Appleton — Length: 07:00 Head-to-head Trial Renews Emphasis on Radiographic Progression as a Therapeutic Goal in Axial Spondyloarthritis Watch Presentation
rheumatology American College of Rheumatology (ACR) Convergence 2022 November 10-14, 2022 — Philadelphia, Pennsylvania Biologics Attenuate Radiographic Progression over 2-Year Period in Patients with Axial Spondyloarthritis Download 4 PowerPoint slides
